Is CD34 truly a negative marker for mesenchymal stromal cells?

References

• da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204–13.
   PubMed Web of Science ®Google Scholar
• Lin CS, Lue TF. Adipose-derived stem cells: characterization and application in urology. In: Illouz YG, Sterodimas A. Adipose Stem Cells and Regenerative Medicine. New York, NY: Springer; 2011. p. 193–207.
   Google Scholar
• Lin CS, Lue TF. Adipose-derived stem cells: therapy through paracrine actions. In: Hayat MA. Stem Cells and Cancer Stem Cells. New York, NY: Springer; 2012. p. 203–16.
   Google Scholar
• Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249–60.
   PubMed Web of Science ®Google Scholar
• Lin G, Garcia M, Ning H, Banie L, Guo YL, Lue TF, . Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008;17:1053–63.
   PubMed Web of Science ®Google Scholar
• Zimmerlin L, Donnenberg VS, Pfeifer ME, Meyer EM, Peault B, Rubin JP, . Stromal vascular progenitors in adult human adipose tissue. Cytometry A. 2010;77:22–30.
   PubMed Web of Science ®Google Scholar
• Maumus M, Peyrafitte JA, D'Angelo R, Fournier-Wirth C, Bouloumie A, Casteilla L, . Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond). 2011;35:1141–53.
   PubMed Web of Science ®Google Scholar
• Corselli M, Chen CW, Sun B, Yap S, Rubin PJ, Peault B. The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev. 2012;21:1299–308.
   PubMed Web of Science ®Google Scholar
• Lin G, Xin Z, Zhang H, Banie L, Wang G, Qiu X, . Identification of active and quiescent adipose vascular stromal cells. Cytotherapy. 2012;14:240–6.
   PubMed Web of Science ®Google Scholar
• Lin CS, Xin ZC, Deng CH, Ning H, Lin G, Lue TF. Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol. 2010;25:807–15.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
   Google Scholar
• Furness SG, McNagny K. Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol Res. 2006;34:13–32.
   Google Scholar
• Pontikoglou C, Deschaseaux F, Sensebe L, Papadaki HA. Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev. 2011;7: 569–89.
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267–74.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, . Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem. 2003;89:1235–49.
   PubMed Web of Science ®Google Scholar
• Simmons PJ, Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood. 1991; 78:2848–53.
   PubMed Web of Science ®Google Scholar
• Kaiser S, Hackanson B, Follo M, Mehlhorn A, Geiger K, Ihorst G, . BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype. Cytotherapy. 2007;9:439–50.
   PubMed Web of Science ®Google Scholar
• Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991;78:55–62.
   PubMed Web of Science ®Google Scholar
• Lin G, Liu G, Banie L, Wang G, Ning H, Lue TF, . Tissue distribution of mesenchymal stem cell marker Stro-1. Stem Cells Dev. 2011;20:1747–52.
   PubMedGoogle Scholar
• Ning H, Lin G, Lue TF, Lin CS. Mesenchymal stem cell marker Stro-1 is a 75 kd endothelial antigen. Biochem Biophys Res Commun. 2011;413:353–7.
   PubMedGoogle Scholar
• Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007; 9:204–13.
   PubMed Web of Science ®Google Scholar
• Watt SM, Karhi K, Gatter K, Furley AJ, Katz FE, Healy LE, . Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells. Leukemia. 1987;1:417–26.
   PubMed Web of Science ®Google Scholar
• Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, . Expression of the CD34 gene in vascular endothelial cells. Blood. 1990;75:2417–26.
   PubMed Web of Science ®Google Scholar
• Muller AM, Hermanns MI, Skrzynski C, Nesslinger M, Muller KM, Kirkpatrick CJ. Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp Mol Pathol. 2002;72:221–9.
   PubMed Web of Science ®Google Scholar
• Testa JE, Chrastina A, Oh P, Li Y, Witkiewicz H, Czarny M, . Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol. 2009;297:L251–62.
   PubMed Web of Science ®Google Scholar
• Unger RE, Krump-Konvalinkova V, Peters K, Kirkpatrick CJ. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res. 2002;64: 384–97.
   PubMedGoogle Scholar
• Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, . Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004;109:656–63.
   PubMed Web of Science ®Google Scholar
• Suga H, Shigeura T, Matsumoto D, Inoue K, Kato H, Aoi N, . Rapid expansion of human adipose-derived stromal cells preserving multipotency. Cytotherapy. 2007;9:738–45.
   PubMed Web of Science ®Google Scholar
• Mouiseddine M, Mathieu N, Stefani J, Demarquay C, Bertho JM. Characterization and histological localization of multipotent mesenchymal stromal cells in the human postnatal thymus. Stem Cells Dev. 2008;17:1165–74.
   PubMedGoogle Scholar
• Stolzing A, Bauer E, Scutt AM. Suspension cultures of bone marrow derived mesenchymal stem cells: effects of donor age and glucose level. Stem Cells Dev. 2012;21:2718–23.
   PubMed Web of Science ®Google Scholar
• Copland I, Sharma K, Lejeune L, Eliopoulos N, Stewart D, Liu P, . CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization. Exp Hematol. 2008;36:93–103.
   PubMedGoogle Scholar
• Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004;103:1662–8.
   PubMed Web of Science ®Google Scholar
• Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273:242–5.
   PubMed Web of Science ®Google Scholar
• Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, . Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997;3:1337–45.
   PubMed Web of Science ®Google Scholar
• Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 1998;4:1038–45.
   PubMed Web of Science ®Google Scholar
• Morel F, Galy A, Chen B, Szilvassy SJ. Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34– fractions of Thy-1lowLin–/lowSca-1+ bone marrow cells. Exp Hematol. 1998;26:440–8.
   PubMed Web of Science ®Google Scholar
• Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. Human bone marrow CD34– cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol. 1998;26:353–60.
   PubMed Web of Science ®Google Scholar
• Donnelly DS, Zelterman D, Sharkis S, Krause DS. Functional activity of murine CD34+ and CD34– hematopoietic stem cell populations. Exp Hematol. 1999;27:788–96.
   PubMed Web of Science ®Google Scholar
• Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999;94: 2548–54.
   PubMed Web of Science ®Google Scholar
• Lange C, Kaltz C, Thalmeier K, Kolb HJ, Huss R. Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34–, Sca-1+, Thy-1(low), c-kit+ stem cell line. J Hematother Stem Cell Res. 1999;8: 335–42.
   PubMedGoogle Scholar
• Huss R. Isolation of primary and immortalized CD34- hematopoietic and mesenchymal stem cells from various sources. Stem Cells. 2000;18:1–9.
   PubMedGoogle Scholar
• He Q, Wan C, Li G. Concise review. Multipotent mesenchymal stromal cells in blood. Stem Cells. 2007;25:69–77.
   PubMed Web of Science ®Google Scholar
• Gangenahalli GU, Singh VK, Verma YK, Gupta P, Sharma RK, Chandra R, . Hematopoietic stem cell antigen CD34: role in adhesion or homing. Stem Cells Dev. 2006;15: 305–13.
   PubMed Web of Science ®Google Scholar
• Nielsen JS, McNagny KM. CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation. 2009;16:487–96.
   PubMed Web of Science ®Google Scholar
• Cheng J, Baumhueter S, Cacalano G, Carver-Moore K, Thibodeaux H, Thomas R, . Hematopoietic defects in mice lacking the sialomucin CD34. Blood. 1996;87: 479–90.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Andrew DP, Gonzalo JA, Fukumoto M, Spellberg J, Hashiyama M, . CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein. Blood. 1996;87:3550–62.
   PubMed Web of Science ®Google Scholar
• Nielsen JS, McNagny KM. Influence of host irradiation on long-term engraftment by CD34-deficient hematopoietic stem cells. Blood. 2007;110:1076–7.
   PubMed Web of Science ®Google Scholar
• Suga H, Matsumoto D, Eto H, Inoue K, Aoi N, Kato H, . Functional implications of CD34 expression in human adipose-derived stem/progenitor cells. Stem Cells Dev. 2009;18:1201–10.
   PubMed Web of Science ®Google Scholar
• Liu JW, Dunoyer-Geindre S, Serre-Beinier V, Mai G, Lambert JF, Fish RJ, . Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost. 2007;5:826–34.
   PubMed Web of Science ®Google Scholar
• Zhang L, Tang A, Zhou Y, Tang J, Luo Z, Jiang C, . Tumor-conditioned mesenchymal stem cells display hematopoietic differentiation and diminished influx of Ca(2+). Stem Cells Dev. 2012;21:1418–28.
   PubMedGoogle Scholar
• Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005;332: 370–9.
   PubMed Web of Science ®Google Scholar
• Goodell MA. Introduction. Focus on hematology. CD34(+) or CD34(–): does it really matter? Blood. 1999;94: 2545–7.
   PubMed Web of Science ®Google Scholar
• Quirici N, Scavullo C, de Girolamo L, Lopa S, Arrigoni E, Deliliers GL, . Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue. Stem Cells Dev. 2010;19:915–25.
   PubMed Web of Science ®Google Scholar
• Ergun S, Tilki D, Klein D. Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal. 2011;15:981–95.
   PubMedGoogle Scholar
• Matsumoto T, Ingham SM, Mifune Y, Osawa A, Logar A, Usas A, . Isolation and characterization of human anterior cruciate ligament-derived vascular stem cells. Stem Cells Dev. 2012;21:859–72.
   Google Scholar